Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 21
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Envoy Medical Inc
COCH
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.6345
-0.0195
-2.98%
Dern. MÀJ: Oct 20, 9:28 AM
$0.6774
0.0234
3.58%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Envoy Medical Financials
Envoy Medical (COCH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Envoy Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $51.000K Miss $80.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 78.13 percent increase over losses of $(0.32) per share from the
Benzinga Newsdesk
PRO
Envoy Medical Q1 EPS $(0.08) Beats $(0.14) Estimate, Sales $39.000K Miss $60.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.14) by 42.86 percent. This is a 72.41 percent increase over losses of $(0.29) per share from the
Benzinga Newsdesk
PRO
Envoy Medical Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $75.000K Beat $70.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the
Benzinga Newsdesk
PRO
Envoy Medical Q3 EPS $(0.35) Misses $(0.28) Estimate, Sales $42.000K Miss $70.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 10.26 percent increase over losses of $(0.39) per share from the
Benzinga Newsdesk
Dow Jumps Over 100 Points; US Crude Oil Inventories Increase
Avi Kapoor
Nasdaq Gains 150 Points; US Mortgage Applications Decline
Avi Kapoor
